KEROS THERAPEUTICS INC's ticker is KROS and the CUSIP is 492327101.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,393 | -49.3% | 43,700 | -36.1% | 0.00% | -50.0% |
| Q2 2023 | $2,748 | -46.9% | 68,400 | -43.5% | 0.00% | -42.9% |
| Q1 2023 | $5,171 | +17.2% | 121,100 | +31.8% | 0.01% | +16.7% |
| Q4 2022 | $4,413 | -99.9% | 91,900 | -5.5% | 0.01% | +20.0% |
| Q3 2022 | $3,657,000 | -6.6% | 97,200 | -31.4% | 0.01% | 0.0% |
| Q2 2022 | $3,915,000 | +1259.4% | 141,700 | +2573.6% | 0.01% | – |
| Q1 2022 | $288,000 | -70.4% | 5,300 | -78.4% | 0.00% | -100.0% |
| Q3 2021 | $972,000 | +36.5% | 24,572 | +143.3% | 0.00% | 0.0% |
| Q4 2020 | $712,000 | +4.2% | 10,100 | -42.9% | 0.00% | 0.0% |
| Q3 2020 | $683,000 | +189.4% | 17,700 | +181.0% | 0.00% | – |
| Q2 2020 | $236,000 | – | 6,300 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Opaleye Management Inc. | 276,000 | $7,626,000 | 3.44% |
| First Light Asset Management, LLC | 598,333 | $16,532,000 | 1.92% |
| Fairmount Funds Management LLC | 272,498 | $7,529,000 | 1.72% |
| Deep Track Capital, LP | 739,528 | $20,433,000 | 1.34% |
| Nantahala Capital Management | 911,901 | $25,196,000 | 1.26% |
| Octagon Capital Advisors LP | 152,249 | $4,207,000 | 1.12% |
| CHI Advisors LLC | 103,429 | $2,858,000 | 1.09% |
| Altium Capital Management LP | 88,000 | $2,431,000 | 0.97% |
| Orbimed Advisors | 1,679,417 | $46,402,000 | 0.84% |
| Parkman Healthcare Partners LLC | 47,788 | $1,320,000 | 0.49% |